GESTODENE/ETHINYLESTRADIOL TEVA 75 micrograms/20 micrograms, coated tablet 63 tablets
Active ingredients: Gestodene, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet63 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GESTODENE/ETHINYLESTRADIOL TEVA 75 microgrammes/20 microgrammes, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) PVC-Aluminium de 21 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 May 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63591253CIP73807252CIP133400938072525Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé | 0,020 mg · un comprimé | SA |
| GESTODÈNEcomprimé | 0,075 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.